Abstract. The expression pattern, subcellular localization, and the role of glycosylation of the human nephrin was examined in transfected cells. Stable cell lines, constitutively expressing a full-length human nephrin cDNA construct, were generated from transfected immortalized mouse podocytes (IMP) and a human embryonic kidney cell line (HEK-293). Immunofluorescence confocal microscopy of transfected cells showed plasma membrane localization of the recombinant nephrin. Immunoblotting showed that the recombinant nephrin expressed in transfected cell lines migrated as a double band with a molecular weight of 185 kD. When cells were treated with the N-glycosylation inhibitor, tunicamycin, the molecular weight of nephrin was decreased to a single immunoband of 150 kD, indicating that the shift in the electrophoretic migration of nephrin is due to N-linked carbohydrate moieties. It was further shown that this glycosylation process is highly sensitive to inhibition by tunicamycin, which is a naturally occurring antibiotic, leading to retention of nonglycosylated nephrin molecules in the endoplasmic reticulum. It was concluded that N-glycosylation of nephrin is crucial for its proper folding and thereby plasma membrane localization; therefore, inhibition of this process might be an important factor in the onset of pathogenesis of some acquired glomerular diseases.
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Ultrafiltration of plasma during formation of the primary urine in the glomeruli is a major function of the kidney. The glomerular ultrafiltration barrier consists of three layers: a fenestrated endothelium, the glomerular basement membrane (GBM), and the podocyte foot processes with their interdigitating slit diaphragms (1) . Characterization of the recently identified gene, NPHS1 (2) , mutated in the congenital nephrotic syndrome of the Finnish type (CNF/NPHS1) has shed new light onto the pathomechanism of the congenital nephrotic syndrome and the glomerular ultrafiltration barrier. The gene product, termed nephrin, is a transmembrane glycoprotein belonging to the Ig superfamily (2, 3) . Nephrin consists of eight extracellular Ig domains, followed by a fibronectin type IIIlike domain, a short transmembrane region, and a cytoplasmic C-terminus. The podocyte-specific expression of nephrin, its localization in the slit diaphragm, and involvement in congenital nephrotic syndrome points to the fact that normal expression and assembly of nephrin is indeed crucial for proper kidney filtration (2-7).
Human nephrin has ten potential N-glycosylation sites in its amino acid sequence (2) , but the process of posttranslational modifications of nephrin in podocytes has not been investigated.
In this study, we report on the role of N-glycosylation in the trafficking of nephrin to the plasma membrane. Using tunicamycin, which inhibits addition of N-linked carbohydrates to the core protein, we have found that nephrin molecules are dependent on N-linked glycosylation for transport to the plasma membrane in transfected podocyte and HEK-293 cell lines.
Materials and Methods

Construction of Full-Length Nephrin cDNA
A full-length cDNA clone encoding human nephrin was cloned into the mammalian expression vector pcDNA3 (Invitrogen, Carlsbad, CA). Briefly, a gt10 clone containing a full-length human nephrin cDNA (4) was used as template in a PCR reaction to introduce a HindIII site into the 5'-end of the clone. The upstream primer, UPHindIII 5'-ACCCTAAGCT-TGCCACCATGGCCCTGGGGA-3', containing the HindIII site (underlined), a short Kozak sequence (italic) followed by the ATG starting codon (underlined and italic), and a downstream primer, DP1 5'-GGGT-CAGCAGGAGCAGCTT-3', were used to amplify a 5'-PCR fragment. The fragment was cleaved with HindIII and EcoRI to generate a HindIII/ EcoRI 5'-end fragment of the full-length clone. This 5'-fragment, together with the rest of the gt10 full-length nephrin clone, were cleaved with EcoRI and KpnI and used to construct a full-length clone that was ligated into a HindIII/KpnI-cleaved pSL1180 vector (Amersham Pharmacia Biotech, Uppsala, Sweden). This construct was cleaved with HindIII and SalI (from the vector) and the nephrin HindIII/SalI-fragment was subcloned into a HindIII/XhoI-cleaved pcDNA3 vector to generate the final fulllength nephrin construct pcDNA3NPH1. The final construct was sequenced to ensure that no mutations had been introduced during PCR and cloning.
Cell Lines and DNA Transfection
A conditionally immortalized mouse podocyte cell line (IMP) was kindly provided by Dr. Peter Mundel (Albert Einstein College of Medicine, NY). The cells were maintained and propagated in RPMI-1640 medium (Life Technologies Inc., Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) as described (8 
Antibodies
For immunofluorescence microscopy, we used a mouse monoclonal antibody (mAb2) raised against the eighth Ig domain of human nephrin, as described previously (9) . Rabbit polyclonal antibodies (pAb2) against the intracellular part of human nephrin was used for immunoblotting (9) . Rabbit anti-calreticulin antibody was purchased from Affinity Bioreagents, Inc. Cyanine (Cy2, Cy3)-conjugated antimouse and anti-rabbit antibodies and horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibodies were from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA) and DAKO (Glostrup, Denmark), respectively.
Tunicamycin Treatment and Immunoblot Analyses
Nephrin-transfected immortalized mouse podocytes (IMP-NPH) or HEK-293 cells (293-NPH) were cultured to almost confluent condition before the tunicamycin treatment. The cells were then washed once with phosphate-buffered saline (PBS) and cultivated for 20 h in fresh culture media in the absence or presence of tunicamycin in a dose-dependent manner. Cells were then washed twice before addition of hot sodium dodecyl sulfate (SDS) sample buffer (63 mM Tris-HCl, 2% SDS, 10% glycerol, 0.1 M dithiothreitol, pH 6.8). The cell lysates were collected with a rubber scraper and passed through 26-gauge needles. The whole cell lysates were transferred into Eppendorf tubes, boiled, and centrifuged for 10 min before loading. The proteins of human isolated glomeruli were extracted by SDS sample buffer. All samples were subjected to SDS-polyacrylamide gel electrophoresis (PAGE) (7.5% gels), and the proteins were transferred onto polyvinylidene fluoride (PVDF) membranes. The membranes were blocked and incubated with affinity-purified pAb2 antibodies (0.2 g/ml), washed, and incubated with HRP-conjugated goat anti-rabbit antibodies. The immunoreactivity was detected by a chemiluminescent kit (Life Science Products, Boston, MA) according to the manufacturer's instructions. The prestained molecular standard used in the SDS-PAGE was from Bio-Rad (Precision Protein Standards, catalog number 161-0372; Bio-Rad, Hercules, CA).
Cell Surface Biotinylation
IMP-NPH cells were cultured in the absence or presence of tunicamycin (5 g/ml) for 20 h. The cells were then washed twice with ice-cold PBS and once with ice-cold Hepes buffer. Cell surface proteins were subsequently biotinylated with 0.5 mg/ml Sulfo-NHSbiotin (Pierce, Rockford, IL) in ice-cold Hepes buffer for 30 min. Nonbiotinylated control cells were washed with ice-cold Hepes buffer containing 50 mM glycine (pH 8.0) and then lysed in 1 ml of RIPA buffer (0.5% sodium deoxycholate, 1% Nonidet-P 40, 0.1% SDS in PBS) containing protease inhibitors, Complete (Roche). The cell lysates were centrifuged at 14.000 g for 15 min to remove insoluble materials. To bind the biotinylated proteins, 40 l Streptavidin-agarose beads (Sigma) was added to each 600-l supernatant lysate and incubated for 2 h at 4°C. The beads were settled by centrifugation, and the supernatants (unbound fractions) were saved. The beads were then washed four times with RIPA buffer, and bound proteins were eluted by addition of hot SDS sample buffer.
Immunofluorescence and Confocal Microscopy
Wild-type IMP and transfected IMP-NPH cells were cultured overnight on glass cover slips coated with laminin 10/11 (Life Technologies). The cells were washed and fixed in a fixing solution (3% formaldehyde, 4% sucrose in PBS) for 20 min at room temperature. After blocking (2% FBS, 3% bovine serum albumin (BSA), 0.2% fish gelatin in PBS) for 1 h, the cells were incubated with affinity-purified monoclonal antibody mAb2 (10 g/ml) for 90 min. The cells were then washed and incubated with Cy2-conjugated anti-mouse IgG for 1 h. To determine the effect of tunicamycin on the subcellular localization of nephrin, IMP-NPH cells were cultured in medium in the presence or absence of tunicamycin (5 g/ml) for 20 h. For doublestaining, the cells were fixed and permeabilized with 0.3% Triton-X100 in PBS for 10 min. After blocking, cells were incubated with the mouse monoclonal anti-nephrin antibody (mAb2) and rabbit anticalreticulin antibodies. The immunocomplexes were visualized with anti-mouse Cy2-and anti-rabbit Cy3-conjugated secondary antibodies, respectively. Confocal sections were analyzed by an Openlab confocal imaging software (Improvision, Coventry, England).
Results
Localization of Human Nephrin in Transfected Podocytes
Due to low endogenous nephrin expression in the cultured immortalized wild-type podocytes, we decided to generate stable cell lines constitutively expressing a full-length human nephrin construct. Several such cell lines with similar expression level and subcellular localization were established. Surface immunofluorescence staining of a nonpermeabilized stable cell line IMP-NPH, using a mouse monoclonal antibody (mAb2) raised against the eighth-Ig domain of human nephrin (9), showed a clear plasma membrane localization of the recombinant nephrin ( Figure 1A) . No positive immunostaining of wild-type mouse podocytes was observed using this speciesspecific monoclonal antibody ( Figure 1B) indicating the specificity of the antibody for the human nephrin. Transfected 293-NPH cells also showed a similar cell membrane immunolocalization of the recombinant human nephrin ( Figure 1C) , whereas the wild-type HEK-293 cells did not show any detectable endogenous nephrin expression ( Figure 1D ).
N-Glycosylation of Human Nephrin
There are ten potential N-linked glycosylation sites in the extracellular part of the human nephrin (2) . When analyzed by SDS-PAGE, the apparent molecular mass of nephrin exceeded that predicted by primary sequence analyses (here and in reference 6). It has also been reported that the shift in molecular migration of nephrin isolated from mouse glomeruli is indeed due to N-glycosylation of the molecule (6).
To find out how much the N-glycosylation of nephrin contributes to the relative molecular migration of the human recombinant nephrin expressed in both IMP-NPH and 293-NPH cell lines, total protein extracts of both transfected cell lines were analyzed by SDS-PAGE and Western blotting using a rabbit polyclonal antibody (pAb2) against the entire intracellular part of the human nephrin (9) . As shown in Figure 2A , the recombinant nephrin in the total extract of IMP-NPH cells migrated as a double immunoband of 185 kD. The total extract of 293-NPH cells also showed a double band with about the same molecular migration. A sample of isolated human glomeruli migrated as a major immunoband of 200 kD and a weak immunoband of the same migration of the lower immunoband from transfected cells (Figure 2A ). When cells were treated with tunicamycin (5 g/ml) for 20 h, both cell extracts showed a single immunoband of 150 kD, indicating that N-linked carbohydrate moieties contribute to a molecular shift of about 35 kD (Figure 2A ). No immunoband was detected when cell extracts from nontransfected cell lines cultured in the same condition were analyzed (data not shown). To investigate the sensitivity of nephrin glycosylation to tunicamycin, both transfected cells were cultured in the absence or the presence of various concentrations of tunicamycin (0.01 to 5 g/ml). As shown in Figure 2B , extremely low concentrations of tunicamycin (0.05 to 0.1 g/ml) could inhibit the N-glycosylation of nephrin core protein in both transfected cell lines, indicating that the N-glycosylation process in both cell lines is highly sensitive to inhibition by Tunicamycin.
N-Glycosylation Is Critical for Proper Folding of Nephrin and Its Localization on the Plasma Membrane
Cell surface biotinylation was used to determine the cell surface expression of nephrin in the absence or the presence of tunicamycin. As shown in Figure 3 , cell surface biotinylated fraction of intact cells clearly showed two immunobands, which due to biotinylation migrated more slowly than the unbiotinylated fraction in the total cell extract. In contrast, in the surface-biotinylated fraction of the tunicamycin-treated cells, no immunoproduct was detected, indicating that nonglycosylated nephrin does not appear on the cell surface. In the tunicamycin-treated cells, nonglycosylated cytosolic fraction of nephrin was shown to migrate as a 150-kD immunoband. The lack of nephrin on the plasma membrane of tunicamycintreated cells was further conformed by double immunostaining of nephrin and calreticulin, an endoplasmic reticulum (ER)- Biotinylated and nonbiotinylated protein fractions were separated by streptavidin agarose beads. The total cell extract (TCE) and biotinylated bound fractions (B) and unbound fractions (U) were analyzed by SDS-PAGE and Western blot analyses using the pAb2 rabbit polyclonal antibodies against the intracellular part of human nephrin. resident chaperon protein. As expected, untreated IMP-NPH cells showed the presence of nephrin in the ER and on the plasma membrane (Figure 4) . In contrast, nephrin was localized only in the ER in the tunicamycin-treated cells (Figure 4) . Altogether, the data showed that glycosylation of nephrin is a prerequisite for its proper folding and transport from the ER to the plasma membrane.
Discussion
The role of nephrin in acquired glomerular diseases is still unclear. However, altered distribution of nephrin has been recently reported in several experimental studies using puromycin-aminonucleoside, which has been proposed as an animal model for minimal-change nephrotic syndrome (10 -12) . A decrease in glomerular mRNA levels of nephrin in the membranous glomerulonephritis and minimal-change nephrotic syndrome has also been reported (13) . Taken together, current data suggest that alteration in normal nephrin expression is involved in some proteinuric states of the acquired glomerular diseases.
In this study, we report on the localization of human nephrin in transfected podocytes and the crucial role of N-glycosylation of nephrin for its localization on the plasma membrane. We also show that this process of glycosylation is extremely sensitive and can be inhibited by small amount (0.05 to 0.1 g/ml) of tunicamycin.
In the ER, N-linked oligosaccharides provide glycoproteins with lectin binding sites, which are necessary for proper folding of the newly synthesized glycoproteins as they pass from one chaperone to another. Interaction between the newly synthesized glycoproteins and the ER resident lectins, such as calreticulin and calnexin, is of great importance for the glycoprotein folding process assisted by the chaperon machinery. The interactions between the glycoproteins and the ER chaperons also provide a quality control mechanism by which nonglycosylated and incorrectly folded glycoproteins retain in the ER and are subsequently transported to cytoplasm for ubiquitination and degradation by proteosomes (14) . Nonglycosylated nephrin in the tunicamycin-treated cells seems to meet the same fate, as it is not transported to the plasma membrane. Whole cell extracts from transfected podocytes and HEK-293 cells, treated with tunicamycin, clearly showed that nephrin is N-glycosylated and that the glycosylation shifts the molecular migration of nephrin by 35 kD. The electrophoretic migration of nephrin as a double band, in both samples of transfected cells and glomeruli, is most likely due to other posttranslational modifications, such as phosphorylation or fatty acid acylation (15) . It should be noted here that the cytoplasmic domain of nephrin contains several potential Tyrphosphorylation sites (2, 7) . In a recent investigation using subcellular fractionation of transfected cell lines, we have found that the lower immunoband corresponds to an intracellular fraction of nephrin, whereas the upper band corresponds to the nephrin fraction with plasma membrane localization (unpublished data). This indicates that the difference in molecular migration between these two protein bands is not due to difference in glycosylation, but rather other posttranslational modifications taking place after the protein has been transported to the plasma membrane. However, the difference in molecular migration of nephrin major band of 200 kD from human glomeruli and that of 185 kD from transfected cells (Figure 2A ) is most likely due to variations or difference in N-glycosylation in the kidney than in cultured cells.
The results from cell surface biotinylation assay together with the co-immunolocalization of nephrin with the ER marker calreticulin clearly showed that nephrin does not appear on the cell surface in tunicamycin-treated cells and instead retains in the ER. On the basis of this study, we conclude that the N-glycosylation of nephrin plays a crucial role in the molecular folding of the protein and that it is therefore critical for plasma membrane localization. It is yet unknown whether an alteration in N-glycosylation of nephrin could be involved in the pathogenesis of some acquired glomerular diseases. However, it has been reported that the disease is associated with missense mutations in some patients with long QT syndrome, leading to alteration of N-glycosylation sites required for the surfacemembrane localization of the HERG protein (16, 17) . In vivo studies have also showed that tunicamycin alters the expression of small intestinal brush border membrane glycoproteins (18) or increases the vascular permeability of the endothelial cells of central nervous system (19) . Because tunicamycin is a naturally occurring antibiotic produced by some fungi, e.g., Streptomyces (20) , or bacteria, e.g., Bacillus cereus (21) , it would be interesting to learn whether glycosylation inhibitors secreted by such microorganisms could be involved in the pathogenesis of some acquired glomerular diseases.
